Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis to in-licence ECF843 for ophthalmic indications globally

pharmaceutical-technologyApril 10, 2017

Tag: Novartis , ophthalmic

PharmaSources Customer Service